Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DX26FFQPU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $49,225
Award facts
- Contract value 100% obligated
- $49,224.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a $49,224.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 10, 2025, represents one of numerous awards issued to DMS Pharmaceutical Group under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group was selected to supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations, with performance scheduled for completion by November 14, 2025.
This delivery order operates under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (SPE2DR) awarded on November 13, 2025, which carries a $499.999 billion ceiling value and extends through December 31, 2036. The PPV-G GEN V program, part of a broader $30.3 billion acquisition strategy, establishes multiple regional prime vendor contractors to provide comprehensive pharmaceutical support to military healthcare facilities worldwide. DMS Pharmaceutical Group's product portfolio encompasses branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning the company as a critical supplier within the federal pharmaceutical supply chain. The contractor has demonstrated substantial performance capabilities through consistent execution of prior delivery orders across diverse therapeutic categories spanning oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals.
Quick answers
Who was awarded contract SPE2DX26FFQPU?
SPE2DX26FFQPU was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on November 10, 2025.
How much is contract SPE2DX26FFQPU worth?
The government has obligated $49,225 on SPE2DX26FFQPU.
Is contract SPE2DX26FFQPU an order under another contract?
Yes. SPE2DX26FFQPU is a delivery order under SPE2DX17D9419, an indefinite delivery contract.
Was contract SPE2DX26FFQPU competed?
The extent of competition for SPE2DX26FFQPU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award